Skip to main content
EnglishEnglish
EnglishEnglishArabicArabicChinese (Simplified)Chinese (Simplified)FrenchFrenchGermanGermanHindiHindiPortuguesePortugueseRussianRussianSpanishSpanishSwahiliSwahili

Header

  • Contact us
  • Subscribe to newsletter
Home The Task Force for Global Health logo
  • https://twitter.com/GlobalHep
  • https://www.facebook.com/GlobalHep/
  • https://www.linkedin.com/company/coalition-for-global-hepatitis-elimination
Donate
Add a Program
Add a Program
Profile
Logout

Main navigation

  • About
    • Who we are
    • What we do
    • Our team
    • Technical Advisory Board
    • Executive Board
    • Donor Acknowledgements
    • CGHE Annual Reports
      • Annual Report 2022
      • Annual Report 2021
      • Annual Report 2020
    • CGHE Publications
  • Partner programs
    • Programs search
  • Data dashboards
    • Country data dashboards
    • National Hepatitis Elimination Profiles
  • Evidence base
    • All evidence (search)
      • Evidence Base Methodology
    • HCV Treatment in Pregnancy
      • Tip-HepC Registry
      • TiP-HepC Systematic Review Results
    • Action Plan Systematic Review
    • Hepatitis B Birth Dose Vaccine Systematic Review
      • Synthesis Brief of Hepatitis B Birth Dose Evidence Base
    • HCV Testing Systematic Review
    • COVID-19 Evidence Hub
      • COVID-19 and Liver Disease Synthesis
      • Clinical Liver Disease COVID-19 special series
        • The COVID-19 Pandemic: An Epidemiologic, Public Health, and Clinical Brief
        • Synthesis of Liver Associations Recommendations for Hepatology and Liver Transplant Care During the COVID-19 Pandemic
    • Innovations in Hepatitis Elimination (CLD Series)
      • Author Interviews
      • Introduction to Series
      • Past Publications
      • Author Guidance
    • Hepatitis Elimination Help Desk
  • Resources
    • Hep C Elimination Tool
      • Access the Tool
      • User Guide
      • Frequently Asked Questions
    • Search resources
    • Technical Assistance Help Desk and Frequently Asked Questions
    • Toolkit: Birth Dose Vaccination in Africa
  • Elimination champions
    • Nominations for Elimination Champions
  • Webinars & Events
    • Hep Test
    • Linkage to care
    • Strategic Information Collaborative
    • Regional Hepatitis Elimination
    • HepB Birth Dose Introduction in AFRO
    • Innovations in Hepatitis Elimination
    • NIH "Moving from Hepatitis Discovery to Elimination"
    • Search webinars
    • Treatment of HCV in Pregnancy for Hepatitis (TiP-HepC)
      • Webinar 1: Challenges
      • Webinar 2: Strategies
  • News
    • Announcements
    • Blog
    • Elimination Champions
    • Events
    • Newsletters
    • Press releases
    • Publications
    • News search
  • UN Group of Friends
  1. Home
  2. Partner programs
  3. Programs search

Programs search

Filter

  • Active
  • Completed
  • Planning
  • Under consideration
  • Hepatitis B
  • Hepatitis C
  • Adolescents (10 - 19 years of age)
  • Adults
  • Adults (> 19 years of age)
  • All ages
  • Birth cohorts of adults
  • Blood transfusion recipients
  • Children (> one year < 10 years of age)
  • Children 5-11
  • Children 12-17
  • Children Under 5
  • General Population
  • Household contact(s)
  • Immigrants/Refugees
  • Incarcerated populations (current and former)
  • Infants (less than one year of age)
  • Men who have sex with men
  • Newborn (born in last 30 days)
  • Newborns
  • Not yet known
  • Occupations with possible exposure
  • People experiencing homelessness
  • Persons who inject drugs
  • Persons with substance use disorder
  • Pregnant women
  • Sexual contact(s)
  • Young Adults <21
  • Global
  • Micro elimination
  • National
  • Regional
  • Sub-National
  • Blood safety
  • Coinfection with HIV
  • Community mobilization
  • Harm reduction
  • HBV perinatal screening and prophylaxis
  • HBV testing and linkage to care
  • HCV testing and linkage to Care
  • HCV treatment
  • Hepatitis B Vaccination
  • Hep B birth-dose vaccination
  • Implementation of birth dose vaccination
  • Implementation of vaccination (general)
  • Injection safety and infection control
  • Linkage to care
  • Persons who inject drugs: HCV cure as prevention
  • Persons who inject drugs: Medication assisted therapy
  • Persons who inject drugs: Syringe service program(s)
  • Prevention mother-child transmission
  • Program evaluation
  • Prophylaxis
  • Safer injection practices
  • Safer sex practices
  • Screening and diagnosis
  • Screening of pregnant women
  • Strategic data analysis
  • Testing
  • Treatment
  • Treatment (direct or referral)
  • Vaccination (general)
  • Albania
  • Armenia
  • Bahamas
  • Belgium
  • Bosnia and Herzegovina
  • Brazil
  • Burkina Faso
  • Burundi
  • Cabo Verde
  • Cambodia
  • Canada
  • Colombia
  • Cote dIvoire
  • Croatia
  • Cyprus
  • Denmark
  • Egypt
  • Ethiopia
  • Fiji
  • Finland
  • France
  • French Polynesia
  • Gambia
  • Georgia
  • Ghana
  • Global
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Ireland
  • Israel
  • Kiribati
  • Kyrgyzstan
  • Latvia
  • Luxembourg
  • Macedonia (the former Yugoslav Republic of)
  • Malawi
  • Malaysia
  • Malta
  • Marshall Islands
  • Mexico
  • Micronesia (Federated States of)
  • Moldova (Republic of)
  • Mongolia
  • Morocco
  • Mozambique
  • Myanmar
  • Nauru
  • New Zealand
  • Nigeria
  • Northern Mariana Islands
  • Norway
  • Palau
  • Papua New Guinea
  • Peru
  • Philippines
  • Poland
  • Portugal
  • Romania
  • Russian Federation
  • Rwanda
  • Senegal
  • Serbia
  • Sierra Leone
  • Singapore
  • Slovakia
  • Slovenia
  • Solomon Islands
  • South Africa
  • Spain
  • Sri Lanka
  • Sudan
  • Sweden
  • Syrian Arab Republic
  • Tajikistan
  • Tanzania
  • Thailand
  • Tonga
  • Tunisia
  • Turkey
  • Tuvalu
  • Uganda
  • Ukraine
  • United Kingdom
  • United States of America
  • Uzbekistan
  • Vanuatu
  • Viet Nam
  • Wallis and Futuna
  • Zambia

Displaying 1 - 12 of 79

  • Mobile Hepatitis B Screening And Vaccination Ghana

    African Region
    Hepatitis B
  • EIVH logo

    ENLIGHTENMENT INITIATIVE ON VIRAL HEPATITIS IN NIGERIA

    African Region
    Hepatitis B
    Hepatitis C
  • HEPSANET

    Hepatitis B in Africa Collaborative Research Network (HEPSANET)

    African Region
    Hepatitis B
  • Hep Free S-W Organization

    African Region
    Hepatitis B
    Hepatitis C
  • Flag of Georgia

    Georgia National HCV Elimination Program

    European Region
    Hepatitis B
    Hepatitis C
  • Pattern of Viral Hepatitis in Ondo State, Nigeria

    African Region
    Hepatitis B
    Hepatitis C
  • Hepatitis Free Mongolia

    Western Pacific Region
    Hepatitis B
    Hepatitis C
  • Peru

    Peru National Viral Hepatitis Program

    Region of the Americas
    Hepatitis B
    Hepatitis C
  • National Task Force Hepatitis B

    National Task Force on Hepatitis B-- United States

    Region of the Americas
    Hepatitis B
  • ELPA

    The European Liver Patients' Association (ELPA)

    European Region
    Hepatitis B
    Hepatitis C
  • Bali Peduli clinic sign

    Bali Peduli -- Indonesia

    Western Pacific Region
    Hepatitis B
    Hepatitis C
  • Armenia flag

    Parenteral viral hepatitis prevention program 2019-2022 (National program)

    European Region
    Hepatitis B
    Hepatitis C

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Next page ››
  • Last page Last »

Contact us

globalhep [at] taskforce.org

Tel: +1-404-371-0466

 

Photos on home page by Tayvessa Wilson, Conor Ashleigh, and Zunaid Murshed Paiker

Support us

Donate

Follow us

  • https://twitter.com/GlobalHep
  • https://www.facebook.com/GlobalHep/
  • https://www.linkedin.com/company/coalition-for-global-hepatitis-elimination

Sign up to our newsletter

<

Footer

  • Contact
© 2019 - 2023 Coalition for Global Hepatitis Elimination
Website by Manta Ray Media